We have cloned Gb 3 synthase, the key ␣1,4-galactosyltransferase in globo-series glycosphingolipid (GSL) synthesis, via a phenotypic screen, which previously yielded iGb 3 synthase, the ␣1,3-galactosyltransferase required in isoglobo-series GSL (Keusch, J. J., Manzella, S. M., Nyame, K. A., Cummings, R. D., and Baenziger, J. U. (2000) J. Biol. Chem. 33). Both transferases act on lactosylceramide, Gal␤1,4Glc␤1Cer (LacCer), to produce Gb 3 (Gal␣1,4LacCer) or iGb 3 (Gal␣1,3LacCer), respectively. GalNAc can be added sequentially to either Gb 3 or iGb 3 yielding globoside and Forssman from Gb 3 , and isogloboside and isoForssman from iGb 3 . Gb 3 synthase is not homologous to iGb 3 synthase but shows 43% identity to a human ␣1,4GlcNAc transferase that transfers a UDP-sugar in an ␣1,4-linkage to a ␤-linked Gal found in mucin. Extensive homology (35% identity) is also present between Gb 3 synthase and genes in Drosophila melanogaster and Arabidopsis thaliana, supporting conserved expression of an ␣1,4-glycosyltransferase, possibly Gb 3 synthase, throughout evolution. The isolated Gb 3 synthase cDNA encodes a type II transmembrane glycosyltransferase of 360 amino acids. The highest tissue expression of Gb 3 synthase RNA is found in the kidney, mesenteric lymph node, spleen, and brain. Gb 3 glycolipid, also called P k antigen or CD77, is a known receptor for verotoxins. CHO cells that do not express Gb 3 and are resistant to verotoxin become susceptible to the toxin following transfection with Gb 3 synthase cDNA.
The glycosphingolipids (GSL) 1 form part of eukaryotic cell membranes. They consist of a hydrophilic carbohydrate moiety linked to a hydrophobic ceramide tail embedded within the lipid bilayer of the membrane. Lactosylceramide, Gal␤1,4Glc␤1Cer (LacCer), is the common synthetic precursor to the majority of GSL found in vertebrates. Hundreds of different glycans are synthesized on LacCer with the major structures grouped into six series (1) . One such series, globo-GSL, is initiated by the action of Gb 3 synthase on LacCer to produce Gb 3 (Gal␣1,4Gal␤1,4Glc␤1Cer). Gb 3 is the P k blood group antigen and has since acquired the designation CD77 (2, 3) . Monoclonal antibodies (mAb) against Gb 3 are used as a marker for Burkitt's B-cell lymphoma and are able to initiate apoptosis (4, 5) . Gb 3 has also been localized to a subset of tonsillar B-cells in the germinal center, platelets, and uroepithelial cells (2, 6, 7) . The B-subunit of Shiga toxins interacts specifically with Gb 3 on the cell surface, thus Gb 3 plays a direct role in toxin entry into the cell (8) . The presence of Gb 3 in the endothelial cells of the kidney of pediatric patients accounts for the development of hemolytic uremic syndrome during bacterial infection with Shigella that produce verotoxin (7) . Recently, Gb 3 has been implicated in the entry of HIV-1 into cells (9, 10) .
In this paper we describe the cloning of Gb 3 synthase, an ␣1,4-galactosyltransferase, and identify significant homology with an ␣1,4-N-acetylglucosaminyltransferase that also transfers to a ␤-linked Gal (11) . Thus, Gb 3 synthase is a member of an emerging family of ␣1,4-glycosyltransferases that utilizes UDP donors and transfers to a ␤-linked acceptor. Additional potential members of this family can be identified in plant, insect, and mammalian sequences submitted to GenBank indicate that this is a highly conserved family of ␣1,4-glycosyltransferases. 3 Synthase cDNA-We have described the phenotypic cloning procedure in detail elsewhere (see Keusch et al., companion paper (39) ). Briefly, a rat placental cDNA library, RPL18, in pCDM8 was cotransfected with large T-antigen cDNA (plasmid pPSVE1 PyE, a kind gift from Dr. Minoru Fukuda, The Burnham Institute) into CHO host recipient cells and surface expression of downstream products, Gb 4 and Gb 5 , were detected using the mAb SMLDN1.1 via flow cytometry (FACS). CHO cells express relatively simple glycosphingolipids, mostly GlcCer, LacCer, and G M3 . Moreover, CHO cells do not express Gb 3 synthase but do express endogenous Gb 4 synthase and Gb 5 synthase. We have previously used this phenotypic screen to clone the iGb 3 synthase (GenBank accession number AF248543, see Keusch et al., companion paper (39) ), and further analysis of clones from the iGb 3 FACS sort which were positive with the SMLDN1.1 mAb (12) yet negative for iGb 3 synthase cDNA revealed a clone capable of synthesiz-* This work was supported by National Institutes of Health Grant R01-DK 41738 (to J. U. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
EXPERIMENTAL PROCEDURES

Expression Cloning of Gb
The 1 The abbreviations for the glycosphingolipids are in accordance with the 1997 recommendations of the IUPAC-IUB Joint Commission of Biochemical Nomenclature. The abbreviations used are: GSL, glycosphingolipid; LacCer, lactosylceramide (Gal␤1,4Glc␤1Cer); Cer, ceramide; Gal, galactose; GalNAc, N-acetylgalactosamine; Glc, glucose; Gb 3 , P k , CD77, or globotriaosylceramide (Gal␣1,4Gal␤1,4Glc␤1 Cer); iGb 3 , isoglobotriaosylceramide (Gal␣1,3Gal␤1,4Glc␤1Cer); Gb 4 , globoside (GalNAc␤1,3Gal␣1,4Gal␤1,4Glc␤1Cer); iGb 4 , isogloboside (GalNAc-␤1,3Gal␣1,3Gal␤1,4Glc␤1Cer); Gb 5 , Forssman (GalNAc␣1,3GalNAc-␤1,3Gal␣1,4Gal␤1,4Glc␤1Cer); iGb 5 , isoForssman (GalNAc␣1,3GalNA-c␤1,3Gal␣1,3Gal␤1,4Glc␤1Cer); mAb, monoclonal antibody; PPPP, 1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol, hydrochloride; TLC, thin layer chromatography; CHO, Chinese hamster ovary; FACS, fluorescence-activated cell sorting; RT-PCR, reverse transcriptase-polymerase chain reaction; PBS, phosphate-buffered saline.
ing Gb 3 . We refer to this latest clone as Gb 3 synthase (accession number AF248544).
cDNA Sequencing-Gb 3 synthase cDNA insert was fully sequenced in both directions using T7, a pCDM8 reverse primer and gene-specific primers, in a reaction mix containing ABI Big-Dye terminators with AmpliTaq DNA polymerase according to the manufacturer's instructions (PE Applied Biosystems). GenBank data bases were searched for homologous sequences using the BLAST (NCBI) program. Membrane topology of Gb 3 synthase was modeled using the transmembrane prediction program TMHMM (13) .
Site-directed Mutagenesis-The 199 DTD 201 sequence in the Gb 3 cDNA clone was mutated to 199 ATA 201 by inverse PCR using high fidelity KlenTaq LA-polymerase mix (Sigma), and completely overlapping primers containing the point mutations (underlined), in the forward direction are: 5Ј-GGTGGCATCTACTTGGCCACAGCCTTCATC-GTCCTCAAG-3Ј and reverse direction: 5Ј-CTTGAGGACGATGAAGG-CTGTGGCCAAGTAGATGCCACC-3Ј were used. Following thermocycling and digestion of parental DNA template with DpnI, MC1061/P3 cells were transformed and mini-preps sequenced to verify the desired mutations.
FACS Analysis-Transfected CHO cells were grown in Ham's F-12 medium supplemented with 10% fetal bovine serum Ϯ 2 M 1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol, HCl) (DL-threo-PPPP, Calbiochem), an inhibitor of glucosylceramide synthase (14) . Cells were harvested 60 h post-transfection using 0.02% EDTA and stained as described (39) . Cell surface GalNAc was detected with the SMLDN1.1 mAb (12) and Gb 3 (Gal␣1,4Gal␤1,4Glc␤1Cer) observed using anti-CD77 mAb clone 38-13 (Biodesign International). Rat mAb M1/22.21 (kindly provided by Dr. Haslam, Washington University, St. Louis, MO) was specific for the Forssman (Gb 5 ) glycolipid (GalNAc␣1,3GalNAc␤1,3Gal␣1,4Gal␤1,4Glc␤1Cer).
Assay of ␣1,4GalT Activity-Cell extracts from transfected CHO cells were prepared and assayed as described previously for the iGb 3 synthase (39) . Glycolipid acceptor substrates included GlcCer, GalCer, LacCer, and Gb 3 (Sigma). Radiolabeled reaction products were isolated on Sep-Pak C 18 columns, then separated via thin layer chromatography (TLC) and exposed to film as described (39) .
Metabolic Labeling of CHO Cells-The day after transfection, CHO cells were labeled with either 35 Ci/ml [ 3 H]Gal or [ 3 H]GlcNAc (NEN Life Science Products), which can also incorporate into GalNAc and sialic acid, for a further 24 -48 h. Cells were scraped off the culture plate, and glycolipids were extracted in chloroform/methanol as described (15) .
Glycolipid Digestion with Exoglycosidases-Glycolipid extracts from transfected CHO cells (approximately 1-10 g or 30,000 cpm) were digested overnight at 37°C with exoglycosidases in the presence of 0.05% sodium taurodeoxycholate in a final volume of 10 l as described (39) .
Shiga Toxin B-subunit in TLC Blots-Glycolipids were extracted from CHO cells cotransfected with plasmid pPSVE1 PyE and either Gb 3 or iGb 3 synthase cDNA and separated by TLC as described (39) . TLC plates were dried by evaporation and either sprayed with orcinol for total glycolipid detection or processed for immunostaining. TLC plates were blocked overnight in PBS/1% BSA. The B-subunit of Shiga toxin (B-Stx-1) was purified to homogeneity, biotinylated, dialyzed, and generously provided by Dr. Haslam, Washington University. The biotinylated B-Stx-1 was diluted 1:1000 in PBS/1% BSA and added for 1 h at room temperature. After washing with PBS, 3 ϫ 10 min, streptavidinperoxidase (Zymed Laboratories Inc.) diluted 1:20,000 in PBS/1% BSA was added for 30 min at room temperature. Blots were washed 6 ϫ 10 min in PBS and developed using chemiluminescence (NEN Life Science Products) according to the manufacturer's instructions.
Verocytotoxicity Assay-Cell sensitivity to verotoxin was measured using an inhibition of protein synthesis assay via Tran 35 S labeling. CHO cells were transiently cotransfected with plasmid pPSVE1 PyE and either Gb 3 or iGb 3 synthase cDNA or empty pCDM8 vector. Transfectants were harvested 48 h post-transfection using 0.02% EDTA, washed in culture media, and plated out in duplicate at 1 ϫ 10 6 cells/ml in 24-well plates in the presence of various concentrations of Shiga toxin-1 (Stx-1, kindly provided by Dr. Haslam) for 4 h at 37°C. The Stx-1 was prepared from a filtered periplasmic extract of cultured bacteria cells containing pNAS13, which carries the Stx-1 operon. Verotoxin and media were washed out and cells incubated in cysteine-, methionine-, SO 4 -free minimal essential medium (Earle's) labeling media for 5 min. Fresh labeling media containing 20 Ci/ml Tran 35 S (ICN) label was added for 30 min. Cells were washed several times in PBS and lysed in PBS/1% SDS/2 mM EDTA and precipitated with ice-cold trichloroacetic acid, final concentration 10%. Following centrifugation, the trichloroacetic acid pellets were solubilized using Protosol (NEN Life Science Products), transferred to scintillation vials containing 3a70B scintillation mixture (Research Products International Corp.), mixed, and counted.
Expression of Gb 3 Synthase in Rat Tissues Using RT-PCR-
The levels of Gb 3 synthase were determined as described (39) . 3 Synthase cDNA via Expression Cloning-Using a phenotypic screen based on recognition of terminal GalNAc by the mAb SMLDN1.1, we identified two independent and nonhomologous ␣-galactosyltransferases that act on LacCer. Initially, iGb 3 synthase was cloned, an ␣1,3-galactosyltransferase that converts LacCer to Gal␣1,3LacCer (iGb 3 ) (39) . Subsequent analysis of additional positive pools of clones revealed Gb 3 synthase, an ␣1,4-galactosyltransferase, that adds galactose onto LacCer to produce Gal␣1,4LacCer. The de novo synthesized products, iGb 3 and Gb 3 , serve as acceptor substrates for endogenous Gb 4 and Gb 5 synthases that are present in the CHO recipient host cell line, thus accounting for the reactivity with the mAb SMLDN1.1 following transfection.
RESULTS
Isolation of a Rat Gb
cDNA Sequence Analysis-DNA sequencing of the Gb 3 synthase clone reveals a 1494-base pair insert with a single open reading frame encoding a protein of 360 amino acids (Fig. 1) . The TMHMM program (13) predicts an N-terminal transmembrane domain of 23 amino acids with a type II transmembrane topology that is characteristic of Golgi glycosyltransferases (16) . The putative catalytic domain of Gb 3 synthase is orientated toward the Golgi, where it is able to interact with its substrate LacCer (17) . This domain also contains two potential N-linked glycosylation sites and a 199 DXD 201 motif common to a number of glycosyltransferases (18) .
Identification of a New ␣1,4-Glycosyltransferase Gene Family-A BLAST analysis of the Gb 3 synthase clone with sequences held in the GenBank data base, reveals a number of genes from a diverse number of species with extensive homology. The highest identity (80%) found is to a human expressed sequence tag clone found on chromosome 22 (accession number HSB33B7). We predict that this is the human homologue of the rat Gb 3 synthase. Furthermore, the Gb 3 synthase is 43% identical to a previously cloned human ␣1,4-N-acetylglucosaminyltransferase (Fig. 2) , found on chromosome 3p14.3, that forms GlcNAc␣1,4Gal␤1,4-R, a glycan found in class III mucin (11) . Long stretches of identity are apparent in the putative catalytic domain, including five conserved cysteines (positions 103, 240, 269, 280, and 349 in rat Gb 3 synthase). Both transferases use a UDP-sugar donor to catalyze the transfer of the sugar in an ␣1,4-linkage to a ␤-linked Gal. Only limited sequence homology has been found between different families of glycosyltransferases, whereas within families there may be extensive homology. For example, the ABO blood group transferases, which now include both Forssman synthase (15) and the iGb 3 synthase (39) , are highly homologous and all produce an ␣1,3-linkage to a ␤-linked Gal or GalNAc utilizing a UDP-nucleotide sugar donor. The extensive homology between Gb 3 synthase and a number of genes from diverse species, including insects, plants, and mammals is, therefore, notable (Fig. 2) . Potential homologues from both Drosophila melanogaster and Arabidopsis thaliana show 35% identity (54% similarity) to Gb 3 synthase, including the location of four cysteine residues in D. melanogaster (equivalent to positions 240, 269, 280, and 349 in rat Gb 3 synthase). Another homologous gene in D. melanogaster (31%, AE003753) is also found that has these four conserved cysteines. Five additional genes with similar degrees of identity to the ␣1,4-glycosyltransferases are identified in A. thaliana. Two of these genes are clustered on chromosome 2, whereas the others are separated on each of the four remaining chromosomes in the genome. The DXD motif, which may play a role in coordinating the nucleotide sugar donor (38) , is maintained in each of the genes homologous to Gb 3 synthase. This suggests that Gb 3 synthase is a member of a family of ␣1,4-UDP-sugar transferases that is highly conserved during evolution. (Fig. 3) . Culture of transfected cells in the presence of PPPP, an inhibitor of glucosylceramide synthase (14) , prevented the appearance of surface material reactive with any of these reagents indicating the products were confined to GSL. A major proportion of the surface GalNAc is due to Forssman glycolipid (Gb 5 ) expression, suggesting that conversion of Gb 3 to Gb 5 is an efficient process (Fig. 3) . Note that CHO cells transfected with Forssman (Gb 5 ) synthase cDNA are unable to synthesize Gb 5 and do not express any terminal GalNAc (Fig. 3) . Thus, the conversion of LacCer to Gb 3 is essential for the subsequent production of Gb 4 and Gb 5 by Gb 4 and Gb 5 synthases that are endogenous to the CHO cells. The conversion of Gb 3 to Gb 4 and Gb 5 is not complete, because surface expression of Gb 3 is detectable using anti-Gb 3 (CD77) mAb (Fig. 3) . (Fig. 4, lane 1) . In addition to the doublets migrating at the position of Gb 4 and Gb 5 , doublets migrating at the positions of Gb 3 , LacCer, and GalCer are seen when the GSL are metabolically labeled with [ (Fig. 4,  lane 3) . Based on the relative intensities of the GSL labeled with [ 3 H]Gal, the majority of the Gb 3 is converted to Gb 4 and Gb 5 , consistent with the pattern of staining seen during FACS analysis (Fig. 3) . Digestion of labeled GSL with ␣-N-acetylgalactosaminidase increased the amount of [ 3 H]Gal label migrating at the position of Gb 4 at the expense of the material migrating as Gb 5 (Fig. 4, lane 4) . In contrast, digestion with ␤-N-acetylhexosaminidase increases the material migrating as Gb 3 at the expense of the material migrating as Gb 4 (Fig. 4,  lane 5 ). Digestion with a combination of ␣-N-acetylgalactosaminidase, ␤-N-acetylhexosaminidase and ␣-galactosidase converts all the labeled material to LacCer (Fig. 4, lane 6) . The pattern of digestion is typical of that obtained with authentic Gb 5 , GalNAc␣1,3GalNAc␤1,3Gal␣1,4Gal␤1,4Glc␤1Cer (19) . The material remaining near the position of Gb 5 (indicated with an asterisk in Fig. 4 ) is attributable to G M3 , which is seen when CHO cells are transfected with the 199 ATA 201 mutant of Gb 3 synthase (Fig. 4, lane 2) , and in nontransfected parent CHO cells (not shown). An interesting feature seen in the Gb 3 synthase sequence is the presence of a DXD motif, previously identified as catalytically important in a number of different glycosyltransferases (18 201 by site-directed mutagenesis results in a loss of Gb 3 activity manifested by a lack of globo-series glycolipid expression following transfection into CHO cells (Fig. 4,  lane 2) . Assuming that both the wild-type and 199 ATA 201 mutant Gb 3 synthase are expressed at similar levels, the mutant expresses a similar set of GSL as found in parent CHO cells. The results confirm that functional Gb 3 synthase is required in CHO cells for the complete production of globo-series GSL.
Cell Surface Expression of Globo-series GSL in CHO Cells
Identification of GSL Synthesized in CHO Cells
In Vitro Enzyme Activity of Gb 3 Synthase-Triton X-100 extracts of CHO cells transfected with Gb 3 synthase cDNA transfer galactose from UDP-[ 3 H]galactose to exogenously added LacCer, whereas parent CHO cells do not (Fig. 5, lane 3,  lower arrow) . Following the enzyme reaction, radiolabeled glycolipid products were isolated via Sep-Pak C 18 and separated by TLC. Low, but detectable, levels of galactose are transferred to GalCer (Fig. 5, lane 2, upper arrow) . No transfer to other GSL tested was detected (Fig. 5, lanes 1 and 4) . Bands present near the origin of the TLC plate are found in assays using extracts from both the parent and Gb 3 synthase transfected CHO cells and are therefore nonspecific. 3 Synthase cDNA-The B-subunit of the verotoxin, Shiga toxin (B-Stx-1), which specifically recognizes Gb 3 , reacts with material migrating at the position of Gb 3 when crude extracts from CHO cells transfected with Gb 3 synthase but not iGb 3 synthase were examined (Fig. 6) . Gb 3 has been identified as the receptor for Shiga toxin, and is required for the transport of the toxin into the cell leading to cell death (8) . Following transfection with Gb 3 synthase cDNA, CHO cells become sensitive to killing by verotoxin. Approximately 65% of Gb 3 synthase cDNA transfectants are killed compared with Ͻ15% of control transfectants (Fig. 7) . Considering that a transfection efficiency of 65-70% is routinely achieved with CHO cells, the verotoxin is highly toxic to the transfected cells.
Functional Gb 3 Is Expressed by CHO Cells Transfected with Gb
Gb 3 Synthase RNA Expression in Rat Tissues-The tissue distribution of Gb 3 synthase RNA was examined by RT-PCR using gene-specific primers. The expected product size of 500 base pairs is found in most tissues, however, the apparent levels of expression varies significantly (Fig. 8) . Tissues with the highest expression include the brain, kidney, mesenteric lymph node, and spleen. Intermediate levels of Gb 3 synthase RNA expression are seen in the adrenal gland, uterus, pituitary, and thymus. All other tissues tested show low/undetectable expression. The expression of glyceraldehyde-3-phosphate dehydrogenase RNA is uniform in these samples. DISCUSSION We have cloned Gb 3 synthase, an ␣1,4-galactosyltransferase that acts on LacCer to form Gb 3 GSL, also known as CD77 or blood group P k antigen (2, 4). Gb 3 synthase initiates the synthesis of the globo-series GSL that includes Gb 4 and Gb 5 , the two products that are detected in the expression cloning procedure. Thus, Gb 3 (P k antigen) is the precursor to Gb 4 , the P antigen, which can then be converted to Gb 5 (Forssman, GalNAc␣1,3Gb 4 ). Gb 3 synthase activity toward LacCer is substantially higher than to another ␤-linked Gal substrate, GalCer, indicating that the correct underlying carbohydrate struc- (lanes 1, 3-6 ture is necessary for efficient enzymatic activity. The Gb 3 synthase sequence should prove useful in the understanding of the genetic defects in the very rare blood group p phenotype, where there is a lack of Gb 3 /P k galactosyltransferase activity and consequently an absence of P k , P, and P 1 antigens (20, 21) . iGb 3 synthase, an ␣1,3-galactosyltransferase (39), and Gb 3 synthase were cloned using the same phenotypic screen, which shows that globoside and Forssman products may be synthesized on either iGb 3 or Gb 3 core structures, to yield iGb 4 and iGb 5 or Gb 4 and Gb 5 , respectively. The presence of isogloboand globo-GSL, which differ only in a positional linkage (␣1,3 or ␣1,4) of the internal ␣-linked Gal, raises questions as to their possible significance. Are globoside and Forssman found in the isoglobo series functionally different from their globo series counterparts? Because products based on globoside, including Forssman, have been identified as stage-specific embryonic antigens (22) , it raises important questions about the role of the underlying core structure (iGb 3 /Gb 3 ). To address these questions we need to examine, in greater detail, the expression of each GSL pathway in different tissues and ultimately different cell types. A comparison of the Gb 3 synthase and iGb 3 synthase expression in rat tissues revealed a broad distribution with varying levels. Six out of the 13 tissues examined show a preferential expression of one of the enzymes, almost to exclusivity, perhaps arguing for distinct functional roles, not only for Gb 3 and iGb 3 but also for their downstream products. In contrast, the spleen and, to a lesser extent, the thymus show high expression of both ␣-galactosyltransferases. GSL structures containing iGb 3 and Gb 3 have been isolated from the spleen (23, 24) . It is notable that the CHO cells transfected with iGb 3 synthase cDNA produced a greater amount of product compared with CHO cells transfected with Gb 3 synthase cDNA in in vitro assays and by FACS analysis. At present, it is unclear what the molecular basis is for this difference, although it raises the possibility that these two enzymes differ in their catalytic efficiency.
The expression of Gb 3 varies with Gb 3 synthase activity in development and cellular differentiation (25, 26) . Although it is unclear what signals these changes, Gb 3 expression has been linked to various pathological events, including hemolytic uremic syndrome, HIV-1 cell fusion, lymphomas, and Fabry's disease (4, 9, 10, (27) (28) (29) . The high expression of Gb 3 synthase activity in the kidney correlates well with Gb 3 expression (30). Children, in contrast to adults, express high levels of Gb 3 in their kidney and as such are at risk to infection by the Shiga toxins (7, 27) . We have shown that CHO cells become susceptible to verotoxin following expression of Gb 3 on their cell surface. Hence, de novo synthesized Gb 3 , in contrast to exogenously added Gb 3 (31) , is functional in CHO cells. Shiga toxin binds specifically to Gb 3 and not to the related iGb 3 GSL. The ability of iGb 3 synthase to out-compete any Gb 3 synthase activity in the same cell may afford the animal protection against infection by bacterial toxins, adhesins, and viruses that interact with Gb 3 . Some bacterial pathogens recognize internal Gal␣1,4Gal structures (iso-receptors) via their P-fimbriae as well as terminal epitopes (32, 33) , so an alternative core (iGb 3 over Gb 3 ) rather than simply capping terminal Gal␣1,4Gal by Gb 4 and/or Gb 5 synthases would be required for resistance.
It is interesting to note that, although Gb 3 synthase and iGb 3 synthase catalyze very similar reactions using the same acceptor substrate (LacCer), they are not homologous. iGb 3 synthase is found to have very high sequence identity to the existing ABO blood group glycosyltransferases, which all catalyze the transfer of a UDP-sugar in an ␣1,3-linkage to either a ␤-linked Gal or GalNAc (39) . In contrast, Gb 3 appears to be a member of a distinct family of glycosyltransferases. These transferases utilize UDP-sugars as the donor to add the sugar in ␣1,4-linkage to a ␤-linked sugar acceptor, most commonly a ␤-linked Gal. Other structures with this linkage have been described, such as the GSL P 1 blood group antigen (Gal␣1,4Gal␤1,3GlcNAc␤1-R) (34), GlcNAc␣1,4Gal␤1-R found in type III mucin in humans (11) , and Gal␣1,4Gal␤1,3GalNAc (35) and GalNAc␣1,4GalNAc␤1,4GlcNAc␤1-R found in insects (36) . The homologues in mammals and insects may thus represent the transferases responsible for the synthesis of these structures. All the homologues to Gb 3 synthase contained the catalytically important DXD motif. Genes encoding sequences with 30-35% identity with Gb 3 synthase can also be identified on the five chromosomes of the plant Arabidopsis, supporting the possibility that the transferases producing structures with ␣ 1,4-linked sugars have been highly conserved during evolution and are therefore of biological importance.
Acknowledgments-We thank Dr. D. Haslam for his helpful suggestions and generous gifts of the anti-Forssman (Gb 5 ) mAb, B-Stx-1, and verotoxin. We are also indebted to Dr. P. Smith for providing the RPL18 cDNA library. FIG. 8. Gb 3 synthase RNA expression in rat tissues. Total RNA was isolated from rat tissues and assayed for the presence of Gb 3 synthase expression (upper panel) using RT-PCR and gene-specific primers. The Gb 3 synthase PCR product (arrow) has the predicted 500-base pair size. Gene-specific primers for glyceraldehyde-3-phosphate dehydrogenase, a housekeeping gene, yielded similar amounts of product from each tissue (lower panel). *, repeat analysis of mesenteric lymph node (mes. LN) and kidney showed the presence of glyceraldehyde-3-phosphate dehydrogenase product. pop. LN, popliteal lymph node; and skel. muscle, skeletal muscle.
